3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
20
Phase 2
7
Phase EARLY_PHASE1
3
Phase 3
2
Phase 1/2
2
Phase 1
2
Phase 2/3
1
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Head & Neck
1
Gynecologic
1
Conditions
Stomach Ulcer
1
Stomach Neoplasms
1
Stomach Diseases
1
Polyposis, Gastric
1
Barrett Esophagus
1
Interventions
Fluorouracil
309
Oxaliplatin
260
Leucovorin
234
Capecitabine
198
Irinotecan
147
Gemcitabine
128
Cisplatin
126
Bevacizumab
119
Radiotherapy
72
Paclitaxel
64
Folfox protocol
56
Cetuximab
56
Drug Therapy
46
Sorafenib
45
Docetaxel
42
S 1 (combination)
40
Chemotherapy, Adjuvant
38
Neoadjuvant Therapy
37
pembrolizumab
36
130-nm albumin-bound paclitaxel
29
Surgical Procedures, Operative
27
regorafenib
25
lenvatinib
24
XELOX
24
Radiation
24
Panitumumab
24
Nivolumab
23
atezolizumab
22
Carboplatin
22
trifluridine tipiracil drug combination
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Endoscopy
×
Gastrointestinal
×
Clear all
NCT02219529
2015-07-21
MCE
Changhai Hospital
Phase 3
Completed
350 enrolled
NCT01209013
2012-05-08
Oedisse
Pinnacle Biologics Inc.
Phase 3
Withdrawn